Mitra Sandip, Chamney Paul, Greenwood Roger, Farrington Ken
Manchester Royal Infirmary, Manchester, United Kingdom.
J Am Soc Nephrol. 2003 Sep;14(9):2345-51. doi: 10.1097/01.asn.0000082998.50730.fa.
Hemodynamic stability during hemodialysis depends largely on plasma volume (PV) preservation during ultrafiltration (UF). Current estimates of blood volume (BV) are indirect or involve the use of radioactive tracers, which does not allow repeated measurements during hemodialysis. Indocyanine green was used to measure PV during hemodialysis. After an initial pilot phase (phase I), PV values were determined before dialysis, repeatedly during isovolemic hemodialysis (phase II), and during stepwise UF (phase III). Absolute BV values were calculated from PV and hematocrit values. Patients were monitored for extracellular fluid volume (bioimpedance monitoring) and relative BV changes (ultrasonic monitoring). Phase I demonstrated dye stability in plasma, peak absorbance at 805 nm, and a short half-life (4.53 +/- 1.5 min). Ten milligrams of dye (2.5 mg/ml) were injected for each PV measurement. Eight plasma samples were obtained beginning 3 min after injection, at 1-min intervals, for assessment of decay characteristics. The isovolemic hemodialysis PV measurements demonstrated excellent reproducibility (r(2) = 0.98; method SD, 356 ml; mean coefficient of variation, 4.07%) and a difference of only 149 +/- 341 ml (mean +/- SD), compared with predialysis PV values (Bland-Altman method). PV values at the beginning of dialysis were significantly correlated with body surface area (r(2) = 0.82, P < 0.001) and extracellular fluid estimates (r(2) = 0.73, P < 0.001). BV prediction formulae significantly underestimated absolute BV at the start of dialysis (P < 0.0001). The findings demonstrate that this method can be used for repeated PV determinations during hemodialysis, with excellent reproducibility. It is a potential tool for further research on hemodynamic stability during UF.
血液透析期间的血流动力学稳定性很大程度上取决于超滤(UF)过程中血浆容量(PV)的维持。目前对血容量(BV)的估计是间接的,或者需要使用放射性示踪剂,这使得在血液透析期间无法进行重复测量。在血液透析期间使用吲哚菁绿来测量PV。在初始试点阶段(I期)之后,在透析前、等容血液透析期间(II期)以及逐步超滤期间(III期)反复测定PV值。根据PV和血细胞比容值计算绝对BV值。对患者进行细胞外液体积(生物电阻抗监测)和相对BV变化(超声监测)的监测。I期证明了染料在血浆中的稳定性、805nm处的峰值吸光度以及较短的半衰期(4.53±1.5分钟)。每次PV测量注射10毫克染料(2.5毫克/毫升)。注射后3分钟开始,每隔1分钟采集8份血浆样本,用于评估衰变特征。等容血液透析PV测量显示出极好的重现性(r² = 0.98;方法标准差,356毫升;平均变异系数,4.07%),与透析前PV值相比,差异仅为149±341毫升(平均值±标准差)(Bland-Altman方法)。透析开始时的PV值与体表面积显著相关(r² = 0.82,P < 0.001)和细胞外液估计值显著相关(r² = 0.73,P < 0.001)。BV预测公式在透析开始时显著低估了绝对BV(P < 0.0001)。研究结果表明,该方法可用于血液透析期间重复测定PV,具有极好的重现性。它是进一步研究超滤期间血流动力学稳定性的潜在工具。